Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MO › Sikeston › NPI 1831269539
Hospital

Missouri Delta Medical Center

Missouri Delta Medical Center was paid $22.69M by Medicaid between Jan 2018 and Dec 2024, across 177 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 11% of everything it billed.

33Billing provider infoMISSOURI DELTA MEDICAL CENTER
SIKESTON, MO 63801
33aNPI1831269539assigned 11/09/2006
28Total paid$22.69M
24GClaims404,854
24DCodes billed177
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Missouri

Rank by total paid#16 of 74
Median peer was paid$4.44M
This provider vs. median5.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SCHRUMPF, JASON controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201841,539$5.65M
201943,973$4.59M
202036,245$2.43M
202150,716$996K
202272,708$2.54M
202395,431$3.74M
2024incomplete64,242$2.75M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 11% 59,980 52,772 $2.46M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.9% 12,778 11,082 $2.25M
X4011 State-specific procedure code 9.7% 10,227 8,244 $2.21M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.8% 10,818 8,761 $2.00M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.3% 10,052 9,451 $1.44M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 6.3% 36,026 29,474 $1.42M
80053 Comprehensive metabolic panel 4.8% 30,375 24,654 $1.10M
87070 3.7% 14,959 12,712 $834K
Y7506 3.2% 5,307 3,350 $731K
Y7507 3.0% 3,491 2,463 $681K
81015 2.6% 15,583 12,850 $596K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.5% 10,127 9,563 $566K
165 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.4% 11,623 $539K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.0% 20,568 $453K
X4003 2.0% 9,245 $450K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.8% 6,244 $400K
71045 Radiologic examination, chest; single view 1.7% 7,335 $378K
81003 1.6% 2,088 $368K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 3,261 $288K
94760 1.1% 3,109 $252K
20553 <1% 3,037 $187K
71046 Radiologic examination, chest; 2 views <1% 1,768 $163K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,719 $158K
20610 <1% 1,167 $119K
84484 <1% 7,623 $118K
70450 Computed tomography, head or brain; without contrast material <1% 2,292 $105K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,551 $102K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,246 $102K
82550 <1% 6,559 $98K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 234 $96K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,281 $93K
59025 Fetal non-stress test <1% 623 $87K
96361 Intravenous infusion, hydration; each additional hour <1% 2,215 $76K
84702 <1% 1,532 $74K
81002 <1% 17,569 $54K
36415 Collection of venous blood by venipuncture <1% 2,140 $52K
83690 <1% 2,477 $52K
86592 <1% 1,164 $45K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 181 $45K
96375 Therapeutic injection; each additional sequential IV push <1% 1,820 $44K
87340 <1% 794 $43K
82553 <1% 3,207 $42K
86701 <1% 419 $41K
84443 Thyroid stimulating hormone (TSH) <1% 3,728 $41K
86762 <1% 754 $39K
73630 <1% 1,044 $39K
86803 <1% 755 $39K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 451 $38K
87634 <1% 1,262 $37K
82947 <1% 549 $34K
94060 <1% 356 $31K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 717 $31K
99213 Doctor's office visit, returning patient (routine) <1% 481 $31K
94761 <1% 645 $30K
71250 <1% 1,042 $29K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 280 $27K
86141 <1% 1,662 $27K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 242 $27K
80061 Lipid panel <1% 2,252 $27K
86900 <1% 443 $26K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 281 $26K
86885 <1% 458 $25K
83880 <1% 2,296 $24K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 180 $23K
36600 <1% 642 $22K
86756 <1% 83 $22K
95117 <1% 991 $21K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 426 $21K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 529 $20K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 639 $20K
87186 <1% 1,039 $20K
87077 <1% 1,040 $20K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 168 $20K
82805 <1% 801 $19K
87653 <1% 357 $19K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 230 $17K
76801 <1% 270 $15K
94726 <1% 225 $15K
83605 <1% 2,192 $14K
83036 Hemoglobin; glycosylated (A1C) <1% 2,115 $14K
84439 <1% 1,620 $12K
80048 Basic metabolic panel (calcium, ionized) <1% 503 $12K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 142 $12K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 168 $12K
80050 General health panel <1% 152 $12K
74022 <1% 42 $11K
17110 <1% 150 $11K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 170 $11K
11043 <1% 33 $11K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 25 $10K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 743 $10K
93041 <1% 49 $10K
83735 <1% 2,374 $10K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials <1% 26 $8K
92557 <1% 185 $8K
85610 <1% 1,510 $8K
86901 <1% 443 $8K
82962 <1% 1,095 $8K
84145 <1% 717 $7K
87040 <1% 898 $7K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 727 $7K
85651 <1% 527 $7K
X4006 <1% 19 $7K
97597 <1% 149 $7K
84703 <1% 1,863 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 496 $6K
73562 <1% 190 $6K
J3490 Unclassified drugs <1% 1,594 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 192 $6K
82950 <1% 457 $6K
72125 Computed tomography, cervical spine; without contrast material <1% 164 $6K
71275 Computed tomographic angiography, chest, with contrast material <1% 95 $5K
52000 <1% 47 $5K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 135 $5K
82607 <1% 195 $4K
62323 <1% 14 $4K
85730 <1% 1,194 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 771 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 245 $3K
73130 <1% 82 $2K
85027 <1% 14 $2K
85007 <1% 14 $2K
64405 <1% 108 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 67 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 64 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 37 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 277 $2K
87220 <1% 274 $2K
94729 <1% 200 $1K
86235 <1% 25 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 13 $974.76
86580 <1% 78 $962.01
87807 <1% 35 $866.94
11056 <1% 19 $865.38
74018 <1% 32 $860.99
82150 <1% 333 $853.18
82105 <1% 14 $785.85
86003 <1% 24 $752.01
71271 <1% 12 $746.07
GO463 <1% 74 $712.39
69210 <1% 41 $668.17
82043 <1% 156 $667.28
85379 <1% 124 $580.40
92588 <1% 13 $571.87
87210 <1% 144 $557.57
80069 <1% 166 $469.24
84207 <1% 14 $397.28
20552 <1% 13 $352.80
84153 <1% 24 $327.41
27096 <1% 26 $286.35
92567 <1% 12 $228.27
88738 <1% 13 $216.66
86038 <1% 28 $201.11
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 607 $193.32
86200 <1% 25 $180.29
82785 <1% 14 $109.59
86431 <1% 26 $89.37
J2704 Injection, propofol, 10 mg <1% 149 $83.66
83721 <1% 12 $78.43
82728 <1% 14 $74.23
82784 <1% 14 $61.95
82570 <1% 29 $53.15
83540 <1% 14 $35.21
84156 <1% 13 $18.10
85018 <1% 20 $14.70
85014 <1% 20 $14.70
84479 <1% 113 $6.38
84436 0% 44 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 65 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 16 $0.00
A9270 Non-covered item or service 0% 35 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 16 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 356 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 15 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 77 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 16 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHRUMPF, JASON (CEO/PRESIDENT)
Same official

Other billing entities under SCHRUMPF, JASON

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.